Wed, Jul 23, 2014, 5:02 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Allergan Inc. Message Board

angelofoca 26 posts  |  Last Activity: Jun 24, 2014 3:24 PM Member since: Dec 15, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    How many of ur friends(now ex)

    by badford59 Jun 24, 2014 2:52 PM
    angelofoca angelofoca Jun 24, 2014 3:24 PM Flag

    I got all my nieces, nephews, my daughter and grandson all in on it -

    They are all averaged in at around $3.60 - $3.70

    popular??? hell yea!!! they can't thank me enough.

    I hope you're short big time, and get your whole family to short it too a$$hole!!!

  • Reply to

    Heavy Put Buying

    by pfort1 May 27, 2014 3:37 PM
    angelofoca angelofoca May 27, 2014 4:01 PM Flag

    you're confused as to how this works - Selling puts at any price is a bullish position - I short would BUY the puts and give you a premim to do so.

    I have sold many many PUTS - for instance the premium paid to me, for the July 7.50 PUT is $3.10 which makes my cost basis on the stock, if put to me at $4.40.

    I have sold PUTS in many strike months and strike price - even this morning I sold some Oct 14 $12.50 PUTS and got $7.30 which makes my effective cost if put to me at $5.20.

  • Reply to

    about Gregory(s)

    by angelofoca May 21, 2014 4:00 PM
    angelofoca angelofoca May 22, 2014 11:44 AM Flag

    Well, Well Well - The OCD basher finally answered my calling LOL... now would you respond to my previous question.

    You've often referred to the Odidi's as goat herders - Now... since their accomplishments are so much greater than yours, - a dejected employee whose main accomplishment in life is to incessantly post drivel on an anonymous message board - and they, the Odidis, can buy you and sell you a thousand times over, - HOW MUCH LOWER THAN A GOAT HERDER DOES THAT MAKE YOU ???

    Are you aware you are in serious need of help???

  • angelofoca angelofoca May 21, 2014 7:33 PM Flag

    State your position on IPCI - are you long short or just sitting on your hands

  • angelofoca angelofoca May 21, 2014 7:31 PM Flag

    LIAR - presentation and presenter both have stated that theirs is best in class resistance

  • Reply to

    about Gregory(s)

    by angelofoca May 21, 2014 4:00 PM
    angelofoca angelofoca May 21, 2014 5:25 PM Flag

    I should add - I have 140K shares of IPCI and I believe it is the best risk reward I've come across in 25 years of investing in emerging biotechs. - This company has it all.

    I've been saying from the beginning - the generics will keep the doors open and the first to file on Seroquel XR will bring in probably $100 Million in 2016 - but it's all about Rexista - best tamperproof technology out there , and Regabatin XR which is a once a day version of 3x a day Lyrica which sells $2.4 Billion a year .

    It's all a matter of WHEN not IF. - Never said soon on Genvec and never said soon here - but if you buy 20,000 shares of IPCI - and forget about the noise here - you'll probably be a MILLIONAIRE in 3 to 5 years. - I expect to be a MULTI-MILLIONAIRE assuming IPCI is not bought out.

  • Reply to

    about Gregory(s)

    by angelofoca May 21, 2014 4:00 PM
    angelofoca angelofoca May 21, 2014 5:04 PM Flag

    ROFLMFAO - I know the difference between LIES and inconvenient truths.

    Post what I ACTUALLY said about Genvec - never said gnvc was SOON going to $200 you lying sack of shet - I said it has the potential to go to $200, still say so, and have been buying the hell out of it today. bought a boat load at 28 cents - made a small fortune - if their hearing technology works, $200 will be cheap.

    You say - defend gregory who i think has brought a lot of good facts to this board -

    ROFLMFAO - he was shouting get out get out at $1.70 - ROFLMFAO - you must have believed him and got out, ROFLMFAO - I bought around 100K shares then - probably the ones you sold.

    You say - take facts wherever you can find them -

    You're a lying sack of sheet trying to pass off lies as facts - you keep repeating that rexista's tamper proof technology has failed when instead it is THE BEST IN CLASS TECHNOLOGY OUT THERE incorporating ALL of the other technology together.

  • angelofoca by angelofoca May 21, 2014 4:00 PM Flag

    Below is a post from the brilliant bigot on this board from Nov 7, 2013 - at the time IPCI was at $1.70

    Just how big of a MORON is this idiot getting 5 cents a post

    gregory03.alan • Nov 7, 2013 7:17 PM Flag
    1users liked this postsusers disliked this posts0Reply
    ICEBERG Dead Ahead !!! DILUTION !!! SOS !!!
    For Any New Investors Looking at IPCI this is a TERRIBLE TIME To Enter !!! Well ANY Time would be TERRIBLE With This Dr DILUTION Ready TO PAY BILLS ONCE AGAIN THRU THE DILUTION OF SHARE HOLDERS VALUE .... JUST LIKE THE PAST & 7 YEARS !!!! OMG !!! Please BEFORE Investing A Single Penny In IPCI you Must Fully Read The November 25, 2011 Press Release Putting $30 MILLION In Stock Printing into This Nigerian CEO Greasy Hands !!!

  • Reply to

    Gimme some...

    by bertrand_sternwood May 21, 2014 9:39 AM
    angelofoca angelofoca May 21, 2014 11:56 AM Flag

    I do hope you're short - why not tell us what and when you short and when you cover

  • Reply to

    Gimme some...

    by bertrand_sternwood May 21, 2014 9:39 AM
    angelofoca angelofoca May 21, 2014 11:53 AM Flag

    I personally believe his crystal ball is far far better tuned than yours

  • angelofoca by angelofoca May 21, 2014 10:41 AM Flag

    My feeling is that they will become a general contractor - selling the generics to "whoever" wants them for a cost plus mark up - if they were't partnered with PAR on focolin, they could now be selling all the focolin strenghts to TEVA, Mylan, Watson etc. who are having manufacturing problems

  • Reply to

    reason for the drop in pps.

    by angelofoca May 1, 2014 1:43 PM
    angelofoca angelofoca May 1, 2014 1:54 PM Flag

    Strange that this release today had no negative effect on pps

    Thursday, May 1, 2014 - 8:00am EDT
    Pfizer Inc. (NYSE:PFE) presented results today from three pivotal studies of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules). One of the studies demonstrates a statistically significant difference in pain scores in patients with moderate-to-severe chronic low back pain receiving ALO-02 versus placebo. The other studies demonstrate lower abuse potential of ALO-02 in recreational opioid users by oral and intranasal routes when compared to immediate-release oxycodone. Data from these three studies were presented at the 33rd Annual Meeting of the American Pain Society (APS) in Tampa, Florida.

  • Reply to

    reason for the drop in pps.

    by angelofoca May 1, 2014 1:43 PM
    angelofoca angelofoca May 1, 2014 1:46 PM Flag

    This was also released yesterday and has a direct bearing on Rexista

    Purdue Pharma L.P. Submits NDA for Once-Daily Hydrocodone Bitartrate Extended-Release Tablets Formulated to Incorporate Abuse-Deterrent Properties

    Data from Clinical Drug-liking Studies Also to be Presented at APS Today

    Stamford, Conn. – April 30, 2014

  • The news release from yesterday may be the reason for the drop in pps.

    I believe Rexista is once a day ... no?

    Teva Reports Positive Results from Pivotal Phase III Study to Evaluate Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Moderate to Severe Chronic Low Back Pain

    Data provides promise for a twice-daily, acetaminophen-free hydrocodone designed with potential abuse-deterrent properties

    JERUSALEM--(BUSINESS WIRE)--April 30, 2014--

  • It appears however that the National health service will not re-imburse the cost - I imagine they can pass this cost on to the patients ?

    - The program requires drugmakers to foot the bill for any and all early access administrations -

    After months of lobbying and speculation, the U.K. has unveiled its Early Access to Medicines Scheme, a program that will allow patients with serious diseases to get access to potentially lifesaving drugs before they're approved.

    Starting next month, the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) will start taking applications from drugmakers who want to participate in the effort. Under the program, MHRA will first apply a so-called promising innovative medicines designation to successful applicants, and then, once it's satisfied with a drug's clinical data, the agency will green-light the treatment for preapproval use.

    The program requires drugmakers to foot the bill for any and all early access administrations, a money-saving move for the U.K.'s National Health Service that isn't sitting very well with the industry. But Ian Hudson, head of MHRA, said pharma will be willing to shell out in exchange for the chance to cull real-world data and forge all-important physician relationships before a drug's proper launch.

  • angelofoca angelofoca Mar 13, 2014 6:52 PM Flag

    they have reserved almost as much booth space as Merck or Celgene - huge footage - there's something we don't know - they are setting up to make a BIG impression.

  • Reply to

    Selling 100% of this position

    by teberb Mar 13, 2014 4:24 PM
    angelofoca angelofoca Mar 13, 2014 4:56 PM Flag

    Never going to hit $50 - within 3 years it will be $15 after twice splitting 2 for 1 when it both times reaches $30.

    By today's price, that will be equivalent to $60.00

  • Reply to


    by teberb Mar 12, 2014 10:17 PM
    angelofoca angelofoca Mar 13, 2014 4:51 PM Flag

    I think you're about the only one on this board that sees the whole picture - it's not about the generics - the generics will keep IPCI from diluting, but all the generics combined don't add up to either Rexista or Regabatin XR

    No one talks about Regabatin, but that goes up against Lyrica, a 3 times a day formulation that sells $2.5 Billion a year - that's Billion with a B - and Regabatin XR is once a day - bound to be best in class!!!

  • angelofoca by angelofoca Feb 25, 2014 10:39 AM Flag

    Step by step, inch by inch she jumps on the shorts and _ucks the in the #$%$

  • angelofoca by angelofoca Feb 20, 2014 11:34 AM Flag

    Take a look on today's chart - it's a thing of beauty - possibly someone knows something!

172.43+2.00(+1.17%)Jul 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.